Yoh K, Matsumoto S, Furuya N, Nishino K, et al. Comprehensive assessment of PD-L1 expression, tumor mutational burden and oncogenic driver alterations in non-small cell lung cancer patients treated with immune checkpoint inhibitors. Lung Cancer 2021;159:128-134.
PMID: 34333203